The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 65 years of age and ...
Portrait of young happy pregnant woman standing by the window Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy ...
Slowly but surely over the last two decades, GSK has worked to give more people access to its tetanus, diptheria and whooping cough vaccine Boostrix. First in 2005, it was adolescents who were cleared ...
April 20, 2009 — The tetanus toxoid/reduced diphtheria toxoid/acellular pertussis single-dose booster vaccine (Tdap; Boostrix, GlaxoSmithKline Biologicals) was approved for an expanded age indication ...
GSK plc GSK announced that the FDA expanded Boostrix’s label for immunization during pregnancy to help prevent pertussis (whooping cough) in infants not older than two months. Following the label ...
PHILADELPHIA, PA -- Dec 8, 2008 -- GlaxoSmithKline (NYSE:GSK - News) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results